Daily as of 3 Nov 16:00 ET
- Price
- below both $26.67 vs 50 $30.24 / 200 $27.91
- Projection
- 💀Death cross projected in 10 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 28 Apr 2026 · projected 17 bars out
NGNE | NeurogeneNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$26.67
+$0.06 (+0.23%)
Neurogene (NGNE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Apr 2026, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily and between the two on the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- between the two $27.29 vs 50 $25.67 / 200 $32.62
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 5 Oct 2026 · projected 28 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 5 Oct 2026 | 💀Death | 4-hour | 28 bars out | Not tested |
| 28 Apr 2026 | 🟨Golden moderate | daily | 17 bars out | Not tested |
| 26 Jan 2026 | 💀Death steep | daily | 26 bars out | 3 bar cross test |
| 22 Aug 2025 | 🟨Golden flat | daily | 26 bars out | 6 bar cross test |
| 19 Dec 2024 | 💀Death | daily | 24 bars out | Not tested |
About NGNE
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$7.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandsmall